CEO Dr. Hanadie Yousef delivered a seminar at the Buck Institute as a distinguished guest speaker highlighting Juvena’s pioneering work in regenerative biologics and AI-driven drug discovery
Juvena Therapeutics presented JUV-161 and JUV-112, at ENDO2025, earning recognition from the Endocrine Society for innovation in metabolic and endocrine health
Dr. Hanadie Yousef participates in the World Economic Forum’s Innovator Communities Meeting and Global Technology Retreat- and shares her expert insights on 2 panels: “Breaking Barriers: Funding Frontier Tech” and “Innovation to Impact: Commercialization Insights from the Field”
CEO Dr. Hanadie Yousef discusses how the success of GLP-1/GIP receptor agonists is reshaping the treatment of chronic metabolic diseases and driving the next wave of therapeutics targeting the biology of aging at BIO 2025 in Boston
CEO Dr. Hanadie Yousef joins a panel of industry leaders at BIO 2025 to explore how emerging therapeutic categories are reshaping dealmaking strategies, investment trends, and positioning in today’s evolving biotech landscape
